Showing 20 of 117 recruiting trials for “acute-myeloid-leukemia-with-t816p11p13-translocation”
SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation
👨⚕️ Uma M Borate, MD, MS, Ohio State University Comprehensive Cancer Center📍 3 sites📅 Started Feb 2024View details ↗
Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)
👨⚕️ Amber Afzal, M.D., MSCI, Washington University School of Medicine📍 1 site📅 Started Feb 2024View details ↗
Cladribine Venetoclax in Monocytic AML
Combination Chemotherapy (FLAG-Ida) With Pivekimab Sunirine (PVEK [IMGN632]) for the Treatment of Newly Diagnosed Adverse Risk Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms
👨⚕️ Jacob Appelbaum, MD, PhD, Fred Hutch/University of Washington Cancer Consortium📍 1 site📅 Started Dec 2023View details ↗
A Study to Evaluate the STI-8591 in Subjects With Advanced Acute Myeloid Leukemia (AML)
RecruitingNCT06116318 ↗
A Study of c-Kit Mutation as MRD in Acute Myeloid Leukemia
Universal CAR-T Cells Targeting AML
Optimizing Induction Chemotherapy Regimens for ND Elderly AML Patients Who Are Eligible for Intense Chemotherapy
👨⚕️ Hui Wei, MD, Institute of Hematology & Blood Diseases Hospital, China📍 1 site📅 Started Oct 2023View details ↗
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
Enrolling by InvitationNCT05212103 ↗
PET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9
👨⚕️ Anne Roivainen, Turku University Hospital, Turku PET Centre📍 1 site📅 Started Sep 2023View details ↗
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
CHIP-AML22/Master: An Open Label Complex Clinical Trial in Newly Diagnosed Pediatric de Novo AML Patients
The Tapering Dose of Luspatercept in Patients With Lower-risk Myelodysplastic Syndromes
RecruitingNCT05902416 ↗
Clinical Registration Study of Haplo-HSCT for Elderly Patients With Acute Leukemia/ Myelodysplastic Syndrome
RecruitingNCT05772559 ↗
Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in Children, Teenagers and Young Adults: Molecular Profiling, Multidrug Testing and MSC Interaction Studies
A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
👨⚕️ Guillermo Garcia-Manero, MD, M.D. Anderson Cancer Center📍 7 sites📅 Started Apr 2023View details ↗
A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies
A Study of Selinexor in Combination With Azacitidine and Venetoclax (SAV Regimen) in Treatment Naïve Participants With Acute Myeloid Leukemia
CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML
Reduced Intensity Conditioning Regimens for Acute Myeloid Leukemia and Myelodysplastic Syndrome
👨⚕️ Linghui Xia, Professor, Department of Hematology, Wuhan Union Hospital, Tongji Medical college, Huazhong University of Science and Technology📍 1 site📅 Started Feb 2023View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →